Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 3. PLD2 and PARN overexpression affects PARN and PLD2 protein and gene expression. PLD2 and PARN overexpression affects PARN and PLD2 protein and.

Published byKelly Skinner Modified over 5 years ago

Similar presentations

Presentation on theme: "Fig. 3. PLD2 and PARN overexpression affects PARN and PLD2 protein and gene expression. PLD2 and PARN overexpression affects PARN and PLD2 protein and."— Presentation transcript:

1 Fig. 3. PLD2 and PARN overexpression affects PARN and PLD2 protein and gene expression.
PLD2 and PARN overexpression affects PARN and PLD2 protein and gene expression. (A) PARN overexpression of catalytically active or deadenylase-inactive (PARN-H377A) plasmids and their effect on PLD2 gene expression in COS-7 cells. (B) PLD2 overexpression of catalytically active or lipase-inactive (PLD2-K758R) plasmids and their effect of PARN gene expression in COS-7 cells. (C-H) Co-expression of PARN and PLD2 in two different cell lines: COS-7 (C,E,G) and MCF-7 (D,F,H). (C,D) Protein expression by western blot (actin was used as a gel loading control). Cells were left untransfected (mock) or transfected with PLD2 or PARN plasmids individually or in combination (PLD2+PARN). (E,F) PLD2 gene expression and (G,H) PARN gene expression, in either case detected by RT-qPCR. Data presented as bars are means+s.e.m. The difference between means was assessed by single-factor ANOVA. *P<0.05, **P<0.01, ***P<0.005, significant increase between samples and controls; #P<0.05, significant decrease between samples and controls. Taylor E. Miller, and Julian Gomez-Cambronero Biology Open 2017;6: © Published by The Company of Biologists Ltd

Download ppt "Fig. 3. PLD2 and PARN overexpression affects PARN and PLD2 protein and gene expression. PLD2 and PARN overexpression affects PARN and PLD2 protein and."

Similar presentations

Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3 Cell Physiol Biochem 2016;40:1221-1229.

Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3 Cell Physiol Biochem 2016;40:
Fig. 5. The measurement of phosphorylation of p53 level in N2A cells under high glucose condition and agmatine treatment. (A, B) p53 phosphorylation levels.

Fig. 5. The measurement of phosphorylation of p53 level in N2A cells under high glucose condition and agmatine treatment. (A, B) p53 phosphorylation levels.
Vegetal RNAs antagonise the dorsalising and BMP-inhibiting activity of Vrtn. Vegetal RNAs antagonise the dorsalising and BMP-inhibiting activity of Vrtn.

Vegetal RNAs antagonise the dorsalising and BMP-inhibiting activity of Vrtn. Vegetal RNAs antagonise the dorsalising and BMP-inhibiting activity of Vrtn.
SP1 was a downstream target of miR-150-3p

SP1 was a downstream target of miR-150-3p
Fig. 6 Combination therapy with LVSOD2 and LVshCTGF preserves flap volume and reduces fibrosis after RT. Combination therapy with LVSOD2 and LVshCTGF preserves.

Fig. 6 Combination therapy with LVSOD2 and LVshCTGF preserves flap volume and reduces fibrosis after RT. Combination therapy with LVSOD2 and LVshCTGF preserves.
Fig. 2. Effect of endurance training on gene expression, and protein content and activity in heart muscle. Effect of endurance training on gene expression,

Fig. 2. Effect of endurance training on gene expression, and protein content and activity in heart muscle. Effect of endurance training on gene expression,
Fig. 4. Clinically defined SMN mutants show alterations in the association with telomerase complex proteins. Clinically defined SMN mutants show alterations.

Fig. 4. Clinically defined SMN mutants show alterations in the association with telomerase complex proteins. Clinically defined SMN mutants show alterations.
Fig. 1. Chlamydia infection causes elevated levels of sortilin.

Fig. 1. Chlamydia infection causes elevated levels of sortilin.
Fig. 4. smc3 regulates the expression of cx43 in regenerating fins.

Fig. 4. smc3 regulates the expression of cx43 in regenerating fins.
Fig. 4. Downregulation of KDM4C restores the integrity of DNA mismatch repair.(A) An outline describing the experimental flow to assess the effect of KDM4C.

Fig. 4. Downregulation of KDM4C restores the integrity of DNA mismatch repair.(A) An outline describing the experimental flow to assess the effect of KDM4C.
The histidine-rich loop regulates accessibility of the active site and RDEL motif in vivo. The histidine-rich loop regulates accessibility of the active.

The histidine-rich loop regulates accessibility of the active site and RDEL motif in vivo. The histidine-rich loop regulates accessibility of the active.
Fig. 2. Proportion of motile objects and track length

Fig. 2. Proportion of motile objects and track length
TC-1 silencing sensitized A549 and SPC-A-1 cells to radiation therapy

TC-1 silencing sensitized A549 and SPC-A-1 cells to radiation therapy
Fig. 7. Knockdown of Meis1 abolishes CR4. 2-GFP expression

Fig. 7. Knockdown of Meis1 abolishes CR4. 2-GFP expression
Fig. 5. Expression of either dFMRP or human FMRP does not induce eIF2α phosphorylation.(A) Analysis of eIF2α phosphorylation upon dFMRP expression. Expression.

Fig. 5. Expression of either dFMRP or human FMRP does not induce eIF2α phosphorylation.(A) Analysis of eIF2α phosphorylation upon dFMRP expression. Expression.
Fig. 4. Expression of p75NTR and time-course of TrkA autophosphorylation at the Y751 and Y490 sites in PC12-27 cells transfected with the vector, empty.

Fig. 4. Expression of p75NTR and time-course of TrkA autophosphorylation at the Y751 and Y490 sites in PC12-27 cells transfected with the vector, empty.
Fig. 1. Lack of Hmga1 and Hmga2 expression in A1/A2-KO mice

Fig. 1. Lack of Hmga1 and Hmga2 expression in A1/A2-KO mice
Fig. 7. E2F1 acetylation in A1/A2-KO MEFs

Fig. 7. E2F1 acetylation in A1/A2-KO MEFs
Fig. 3. Characterization of unclassified cells (UCs).

Fig. 3. Characterization of unclassified cells (UCs).
Fig. 2. Ex vivo inducible knockout of PDCD2 in ESCs results in loss of S phase entry and increased p53.(A) Growth curve of inducible knockout and WT ESCs.

Fig. 2. Ex vivo inducible knockout of PDCD2 in ESCs results in loss of S phase entry and increased p53.(A) Growth curve of inducible knockout and WT ESCs.

Similar presentations

Ads by Google